Equity Update: Equity Slide Continues Equity Update: Equity Slide Continues Equity Update: Equity Slide Continues

Equity Update: Equity Slide Continues

Equities 8 minutes to read

The spread of the virus and the fear that this brings with it continues to infect nations as well as the fragilities rendered by globalisation and heavily intertwined supply chains. This along with the mounting economic damage of preventative actions to control the spread of the COVID-19 outbreak, continues to roil investors nerves. The Feds emergency 50bps rate cut and the Biden bounce provided fleeting relief for risk assets that have otherwise struggled with the left tail outcomes of a global pandemic this week. This uncertainty is reflected in the VIX, which has remained stubbornly above 30 for the longest period since 2011. Government bond yields continue to set record lows as investors seek portfolio buffers and price recession risk along with continued monetary easing, the US 10-year yield plunging below 0.82bps and the 30-year dropping ~10bps in a matter of hours throughout Asia trade to 1.43% at the time of writing. This collapse giving gold the green light, amongst other factors as our Commodity Strategist highlights. The constant flow of COVID-19 headlines continues to drive sentiment and waves of selling across the risk asset spectrum, with equity indices swinging wildly between gains and losses and havens continually reaching fresh records as risk aversion remains elevated.

The erratic swings throughout the week have been exacerbated by the present high volatility regime. This combined with above average volumes and lower liquidity, which is highly negatively correlated with volatility, creates a self-perpetuating feedback loop and increase in systematic selling that exaggerates daily price movements.

Forecasting the ultimate outcome remains a fruitless task given the cascading unknowns as it relates to containment of COVID-19 and the economic ramifications of travel bans, shutdowns and quarantines flowing through to activity, cash flow, corporate profits and confidence. But one thing is for sure, liquidity and rate cuts wont contain the virus, presenting market participants with an unprecedented set of ambiguities as monetary policy has already been stretched to the end of it tether. Nevertheless, the cavalry is here, with the RBA, Fed, BoC all delivering rate cuts this week. But conventional monetary policy is out of ammo in the virus fight. Central banks will do what they can to support financial conditions and forestall corporate casualties, but it won’t be that easy. Once again the market is front running the Fed, the market has completely priced another 50bps cut at the March 18 meeting as the global case count rises and the inevitable hit to economic output increases. If the COVID-19 outbreak continues to spread, inflicting unbounded economic displacements the Feds hand will be forced once more in order to support financial conditions and maintain liquidity for SMEs buckling under the weight of reduced demand or supply chain dislocations. Containing credit dislocations and preventing SME cashflows from drying up whilst revenues and operating incomes are scourged will keep policymakers in the hotseat as the double whammy demand and supply shock hits economic activity. Another reason why yields continue to track lower as any incremental price increases coming from supply chain disruptions are dwarfed by a collapse in demand which dominates. Consumer confidence suffers a dual hit via the wealth effect as stock prices fall, particularly prevalent in the US where consumer confidence and the S&P 500 returns are highly correlated given household exposure to equities, but also via the virus fear factor that inhibits discretionary spending and keeps people home.

Heading into the weekend as the US continues to expand testing and the headlines keep rolling it is our view that equities remain under pressure as traders de-risk, as we saw last week. The February nonfarm payrolls data will be irrelevant in the face of the unfolding and fluid developments surrounding the COVID-19 outbreak. The number of confirmed infections is likely to rise significantly in the US, comparing the current fatality rate in the US of 7% vs. approximately 1% in other countries implies the case count in the US is currently understated due to the lack of testing. This could well be the trigger for another bout of market volatility or at least a gap lower on Monday’s open, particularly whilst sentiment remains fragile, liquidity is thin and the VIX is already elevated. Now the emergency cut from the Fed has been fired there is nothing to stop bears taking control if bad news multiplies. For markets to really recover the onus will be on reduced COVID-19 transmission rates, increased immunity and a clear containment of the outbreak, only then will the downside risks to economic activity diminish.

Funding Stresses

Risk assets are focussed on an acute hit to growth but also the risk that the hit becomes more chronic via the effects on supply chains and potential credit dislocations amongst overindebted corporates. Airlines, hotels, leisure providers and autos are the most at risk industries here.

That is why the real support markets need is lacking, as outlined above rate cuts don’t fix the impending demand and supply shock that results from a pandemic virus. Instead coordinated policy action is needed to provide emergency financial support and credit lines for businesses temporarily affected by the impacts of the virus outbreak. This is key to protecting jobs and avoiding a more broad based financial shock. The problem here is the obvious limitations in implementing these support measures in a timely and efficient manner.

The incoming governor of the Bank of England, Andrew Bailey, has appealed to the government to offer emergency financial support for British companies in the midst of the coronavirus outbreak. Warning that “We are collectively now going to have to provide some form of supply chain finance in the not too distant future.” In the US similar measures are being debated in order to maintain bank provisions for businesses that are facing cashflow strains as operating incomes and revenues dry up due to demand or supply dislocations. Because it is these individual firms that collectively raise contagion risk for banking systems the longer this economic shock persists.

Credit will be in the hotseat as the economic fallout from the virus outbreak is monitored along with the emergency monetary and fiscal responses. The secondary and tertiary ripple effects via supply chain disruptions and potential funding and financing problems is where the bulk of uncertainty lies. Likely becoming a key decider in a temporary hit to earnings vs. a recession.

Source: Bloomberg, high yield CDX (inverted) vs. SPX

Plan for the best and prepare for the worst

Given the elevated tail risks of unknown magnitude we remain defensively positioned with a focus on capital preservation. We stick with our overweights in gold, silver and US treasuries relative to equities. Buying the dip not recommended unless its gold!

Looking at these moves across markets we have gathered a selection of ETFs and individual names that can be used as inspiration for trading the COVID-19 themes we have spoken about above. These are by no means meant to be trading ides, but rather to serve as inspiration.

Our Strategy team have more on trading Coronavirus here:



Quarterly Outlook 2024 Q3

Sandcastle economics

01 / 07

  • Macro: Sandcastle economics

    Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.

    Read article
  • Bonds: What to do until inflation stabilises

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain inflation and evolving monetary policies.

    Read article
  • Equities: Are we blowing bubbles again

    Explore key trends and opportunities in European equities and electrification theme as market dynamics echo 2021's rally.

    Read article
  • FX: Risk-on currencies to surge against havens

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperform in Q3 2024.

    Read article
  • Commodities: Energy and grains in focus as metals pause

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities in Q3 2024.

    Read article
  • The rise of populism: Far-right parties will influence the future

    The disheartening cycle of unresolved geopolitical conflicts, the rise of polarizing political parties, and the stagnation of productivity.

    Read article
  • Investing in China: Navigating Q1 amid economic challenges

    Understand China's political landscape in Q4 2023 and the impact on counter-cyclical initiatives, with a focus on the pivotal Q1 2024.

    Read article

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.